CONNECT WITH US
Fintech

Fintech

Oura Buys AI Firm Counsel Health in $625 Million Deal

PYMNTS – Fintech logo

Published on

Add as a preferred source on Google
Oura Buys AI Firm Counsel Health in $625 Million Deal

Smart ring maker and health intelligence platform Oura is set to acquire artificial intelligence (AI) health company Counsel Health.

Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

The $625 million deal, announced in a news release Tuesday (Nov. 10), follows the recent postponement of Oura’s initial public offering (IPO).

“Founded and built by physicians and AI researchers, Counsel combines medical AI with in-house physicians to deliver immediate, high-quality guidance and care,” the release said. “By pairing Oura’s continuous biometric data with Counsel’s platform and on-demand human doctors, Oura Members receive care across a spectrum of needs.”

According to the release, members can start from an “Oura insight” or immediately chat with Counsel’s medical AI to receive personalized medical advice. Conversations can escalate to a board-certified Counsel physician within minutes as needed. The company said the deal delivers on its vision of “more proactive, personalized healthcare Counsel’s vision of expanding access to care using “responsibly designed” medical AI.

“Oura helps members understand their physiology and, with Counsel, they can take action on their health across a range of needs, from quick questions and prescriptions to lab results, chronic care, and referrals,” said Tom Hale , CEO of Oura. “Together, we can create a new model of care that extends the current healthcare paradigm by delivering an experience that’s more immediate, personalized, and proactive.



Source link
Related Topics:Fintech

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.